- News & Analysis
- Home
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Publications
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- Video
- Subscribe
- Newsletters
- Events
Page 41
Analysis: Prenetics in a $1.25bn reverse merger
Alibaba and Ping An-backed Prenetics is set to complete a reverse merger at a $1.25bn valuation. Exits from the broader genetics and gene therapeutics space appear to be in the middle of a valuation spike, according to our data.
Sep 20, 2021Daily Deal Round Up: September 17, 2021
Conductive Ventures returned for online savings platform developer Self Financial's $50m series E round while EV producer Volta Trucks completed its $43.6m series B.
Sep 17, 2021Prenetics tests out $1.25bn reverse merger
Alibaba and Ping An-backed genetic testing services provider Prenetics will hold a reverse merger at a $1.25bn valuation, securing $120m in Pipe financing.
Sep 16, 2021Daily Deal Round Up: September 15, 2021
Online furniture retailer Gaia, warehouse robot provider Locus Robotics, recruitment platform developer Canvas and ESG software producer Measurabl all raised $50m.
Sep 15, 2021SpotOn tables Appetize acquisition
R/GA, Oak View Group and 32 Equity are set to exit POS technology developer Appetize in an acquisition by SpotOn potentially sized at about $300m.
Sep 15, 2021Tenable tends to $160m Accurics acquisition
Tenable is set to purchase the cloud-native security software provider, which has raised $20m from investors including Intel Capital.
Sep 15, 2021Daily Deal Round Up: September 14, 2021
Samsung-backed automation software developer Rezilion secured $30m while IGC Hospitality took part in restaurant management technology provider MarginEdge's $18m series B round.
Sep 14, 2021Forge Global hammers out $2bn reverse takeover
Deutsche Börse, Munich Re and Wells Fargo will secure exits through a deal that will give the private shares marketplace a public listing.
Sep 14, 2021Daily Deal Round Up: September 13, 2021
UPS is buying delivery service Roadie having helped it raise $62m while heart disease treatment developer Nectero Medical secured $19.5m in a Boston Scientific-led round.
Sep 13, 2021Exscientia explores Nasdaq IPO
Dundee spinout Exscientia has filed for an offering that would provide exits for SoftBank Vision Fund 2, Novo, BMS, Celgene, Evotec and Pivotal BioVenture Partners.
Sep 13, 2021
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.